Please Login to read the full article.
Clinica
Quarterly results round-up: Covidien shows strong start, Recon still weak but other units give boost to Zimmer and Stryker
27 January 2012
Madeleine Armstrong
Please Login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
- Quarterly results round-up: Bard and Zimmer in line, while Grifols stays strong
- Quarterly results round-up: Boston hit by weak CRM market, Styker's profits down again
- Quarterly results round-up: Abbott staying conservatively optimistic, Quest and St Jude see profits fall
- Quarterly results round-up: “no better, no worse” for Bard, Roche suffers from exchange rates again
Other Informa News
EVENTS
